Medicare Enrolled

Dr. Lori Michelle Laffel, M.D.

Pediatric Endocrinology · Boston, MA
Consulting-driven
ONE JOSLIN PLACE, Boston, MA 02215
6177322603
In practice since 2006 (20 years)
NPI: 1275570228 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Laffel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laffel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Laffel

Dr. Lori Michelle Laffel is a pediatric endocrinology specialist in Boston, MA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Laffel received a total of $297,870 from 25 pharmaceutical and/or device companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric endocrinology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Laffel is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $297,870 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$297,870
Total received (2018-2024)
Avg $42,553/year across 7 years
Top 0% in MA for pediatric endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
272
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$189,163 (63.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$67,623 (22.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$41,084 (13.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18,415
2023
$27,472
2022
$54,239
2021
$28,071
2020
$39,470
2019
$52,405
2018
$77,796

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$8,659
Boehringer Ingelheim International GmbH
$6,798
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,241
VERTEX PHARMACEUTICALS INCORPORATED
$528
Mannkind Corporation
$119
Tandem Diabetes Care, Inc.
$71
Top 3 companies account for 96.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$39,830
Boehringer Ingelheim International GmbH
$38,913
SANOFI-AVENTIS U.S. LLC
$28,364
Janssen Research & Development, LLC
$26,400
Dexcom, Inc.
$25,350
Boehringer Ingelheim Pharmaceuticals, Inc.
$24,810
Roche Diabetes Care GmbH
$21,874
Eli Lilly and Company
$21,083
Novo Nordisk Inc
$20,376
Novo Nordisk AS
$14,421
Medtronic MiniMed, Inc.
$10,555
Merck Sharp & Dohme Corporation
$4,400
Insulet Corporation
$4,041
Lexicon Pharmaceuticals, Inc.
$3,440
ConvaTec Inc.
$3,200
Roche Diabetes Care, Inc.
$2,900
Vertex Pharmaceuticals Incorporated
$2,833
Dompe US, Inc.
$1,800
AstraZeneca AB
$1,650
VERTEX PHARMACEUTICALS INCORPORATED
$528
MannKind Corporation
$353
Tandem Diabetes Care, Inc.
$296
Abbott Laboratories
$291
Mannkind Corporation
$119
LIFESCAN, INC.
$43
Top 3 companies account for 36.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AQUACEL AG · Accu-Chek Inform II Instrument with RF card · Accu-Chek Instruments · Cables · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · Dexcom CGM · Dexcom G6 Transmitter · FIASP · HUMALOG · INVOKANA · JARDIANCE · Kits and Accessories · Ladarixin · MINIMED 770G · MINIMED 780G · Minimed 670G System · Minimed 770G System · NO PRODUCT DISCUSSED · ONGLYZA · Omnipod · SOTAGLIFLOZIN · Software · TZIELD · Tresiba · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for pediatric endocrinology in MA.

Looking for a pediatric endocrinology specialist in Boston?
Compare pediatric endocrinologists in the Boston area by procedure volume, costs, and industry payment transparency.
Browse pediatric endocrinologists nearby

Geographic Context

Pediatric endocrinologists within 10 mi
69
Per 100K population
8.8
County median income
$92,859
Nearest hospital
BETH ISRAEL DEACONESS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Laffel is a pediatric endocrinology specialist, with consulting-driven industry engagement in the top 0% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Laffel receive payments from pharmaceutical companies?
Yes. Dr. Laffel received a total of $297,870 from 25 companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Laffel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →